Fact CheckerSign in

NCT05140226Completed

Cognitive and Physical Training in Patients With Chronic Obstructive Pulmonary Disease Patients

Feasibility of a Home-Based Cognitive-Physical Exercise Program in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 29 Sept 2025

Brief summary (registry, in English)

Cognitive and physical function impairments are common in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Research has shown that cognitive and physical exercise training may be a beneficial strategy to improve physical and cognitive performance in COPD patients; however, interventions combining physical and cognitive training have not been evaluated in this population. The objectives of this research are i) to evaluate the feasibility of an 8-week home-based cognitive-physical training program in COPD patients; and ii) to derive preliminary estimates on intervention efficacy with cognitive-physical training on dual-task performance, physical function, activities of daily living, and health-related quality of life. Related to our research objectives, we hypothesize that i) it will be feasible to safely recruit COPD patients into a home-based cognitive physical training program with 75% adherence and high satisfaction ratings with the prescribed training; and that ii) the combination of cognitive and physical training will be superior to physical training alone for improving dual-task and cognitive performance, physical function, activities of daily living, and health-related quality of life.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
17 Nov 2021
Start date
1 Mar 2022
Primary completion date
22 Sept 2025
Lead sponsor
University Health Network, Toronto
Diseases
COPD
NCT number
NCT05140226

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 1 Mar 2022 to the primary completion date, 22 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient on home oxygen therapy
  • Patient actively listed for lung transplantation

Other illness

  • Disease exacerbation in the past 3 months
  • Diagnosis of a neurological or musculoskeletal condition that would interfere with safe performance of study tests (e.g., stroke, myopathy, inflammatory arthritis)
  • Severe cognitive impairment ascertained by chart review or self-reported
  • Coronary artery disease, pacemaker or implantable defibrillator, clinical diagnosis of congestive heart failure (CHF), or poorly controlled arrhythmias
  • Medical instability (hepatic dysfunction, metabolic abnormalities, or active infection)
  • Overt psychiatric disorder or substance abuse

Other

  • Current participation in a pulmonary rehabilitation program
  • Insufficient English fluency and cognition to carry out testing and training

Who the study is looking for

  • Adult participants (≥ 50 years of age)
  • Clinical and spirometric diagnosis of COPD (FEV1 30-80%)
  • Access to reliable internet connection
  • Ability to mobilize independently and safely, with or without a walking aid

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Health Network
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.